Share on StockTwits

Stock analysts at RBC Capital reduced their price target on shares of Core Laboratories (NYSE:CLB) from $235.00 to $180.00 in a report issued on Tuesday, ARN reports. The firm currently has a “sector perform” rating on the stock. RBC Capital’s price objective points to a potential upside of 7.77% from the company’s current price.

CLB has been the subject of a number of other recent research reports. Analysts at Barclays cut their price target on shares of Core Laboratories from $198.00 to $181.00 in a research note on Monday. Separately, analysts at Morgan Stanley upgraded shares of Core Laboratories from an “underweight” rating to an “equal weight” rating in a research note on Monday. Finally, analysts at Iberia Capital downgraded shares of Core Laboratories from an “outperform” rating to a “sector perform” rating in a research note on Monday. Eleven analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Core Laboratories presently has a consensus rating of “Hold” and a consensus target price of $182.00.

Shares of Core Laboratories (NYSE:CLB) opened at 167.02 on Tuesday. Core Laboratories has a 52 week low of $133.02 and a 52 week high of $221.00. The stock’s 50-day moving average is $197.4 and its 200-day moving average is $190.5. The company has a market cap of $7.495 billion and a price-to-earnings ratio of 34.95.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, April 23rd. The company reported $1.35 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.45 by $0.10. The company had revenue of $262.90 million for the quarter, compared to the consensus estimate of $283.02 million. During the same quarter in the prior year, the company posted $1.22 earnings per share. The company’s quarterly revenue was up .8% on a year-over-year basis. On average, analysts predict that Core Laboratories will post $6.20 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, May 23rd. Investors of record on Friday, April 25th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.20%. The ex-dividend date is Wednesday, April 23rd.

Core Laboratories N.V. (NYSE:CLB) is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.